Stay updated on Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial

Sign up to get notified when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    An NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” across NIH content. The underlying study page remains a 403 error.
    Difference
    1%
    Check dated 2026-10-24T18:52:53.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision number changed from v3.7.1 to v3.7.2; the study record remains inaccessible on the 403 page.
    Difference
    0.2%
    Check dated 2026-10-17T20:43:33.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The revision identifier in the page footer updates from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T20:52:17.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previously visible study record content and signaling restricted access to the study information. A basic 403 header and navigation appear where study details used to be.
    Difference
    22%
    Check dated 2026-09-19T22:25:10.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The study record adds an NIH funding note for 2017 and updates the document version to v3.6.6, while removing the previous v3.6.5 version.
    Difference
    0.1%
    Check dated 2026-08-29T20:19:37.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was added and Revision: v3.6.4 was removed, signaling a minor update to the page's version or underlying content.
    Difference
    0.1%
    Check dated 2026-08-08T18:36:04.000Z thumbnail image

Stay in the know with updates to Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.